Daily Archives: December 18, 2008

FDA Announces New Recommendations on Evaluating Cardiovascular Risk in Drugs Intended to Treat Type 2 Diabetes

Cardiovascular risk associated with diabetes has been a major issue for those developing medications for diabetics.  Yesterday, the FDA issued a press release about new diabetes drug development guidelines that the agency is issuing in relation to the evaluation of … Continue reading

Posted in FDA Policy | Comments Off